Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-12-26
2006-12-26
Campell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
Reexamination Certificate
active
07153513
ABSTRACT:
The present invention provides a safe and effective vaccine composition against West Nile virus disease. An immunogenically active component of West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine. The invention also provides a method for the prevention or amelioration of West Nile disease, such as encephalitis, in equidae by administering the vaccine composition herein set forth.
REFERENCES:
patent: 6184024 (2001-02-01), Lai et al.
patent: 2002/0164349 (2002-11-01), Weiner et al.
patent: 2003/0022849 (2003-01-01), Chang
patent: 2003/0104008 (2003-06-01), Loosmore et al.
patent: WO 99/63095 (1999-12-01), None
patent: WO 02/068637 (2002-09-01), None
patent: WO 02/072036 (2002-09-01), None
patent: WO 02/081621 (2002-10-01), None
patent: WO 02/081754 (2002-10-01), None
patent: WO 02/083903 (2002-10-01), None
patent: WO 2004-016586 (2004-02-01), None
Price et al. Live and Inactivated vaccines of group B Arboviruses: Role of neutralizing antibody and serum protective factor. Nature (1969) vol. 222, pp. 1294-1295.
Imam et al. Challenge of hamsters with Japanese B, St. Louis and Murray Valley encephalitis after immunization by West Nile infection plus specific vaccine. Journal of Immunology (1957) vol. 79, No. 3, pp. 243-252.
Steele et al. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Veterinary Pathology (2000) vol. 37, pp. 208-224.
Anderson, John F., et al., “Isolation of West Nile Virus from Mosquitoes, Crows, and Cooper's Hawk in Connecticut,” Science, Dec. 17, 1999, pp. 2331-2333, vol. 286.
Senne, D.A., et al., “Pathogenicity of West Nile Virus in Chickens,” Avian Diseases, 2000, pp. 642-649, vol. 44.
B. S. Davis, et al.; “West Nile Virus Recombinant DNAVaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen that can be used in Enzyme-Linked Immunosorbent Assays;” Journal of Virology; May 2001; p. 4040-4047; vol. 75, No. 9.
G. J. Chang, et al.; “A Single Intramuscular Injection of Recombinant Plasmid DNA Induces Protective Immunity and Prevents Japanese Encephalitis in Mice;” Journal of Virology, May 2000, p. 4244-4252; vol. 74, No. 9.
Hammon, W. McD. et al., “Immunity of Hamsters to West Nile and Murray Valley Viruses Following Immunization with St. Louis and Japanese B.,” Proc. Soc. Exper. Biol. & Med., 1956, pp. 521-523, vol. 91.
Xiao, Shu-Yuan et al., “West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis,” Centers for Disease Control, Jul.-Aug. 2001, Entire 14-page Article, vol. 7, No. 4.
Campell Bruce R.
Cottingham Frank R.
Salvoza M. Franco
Wyeth
LandOfFree
West nile vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with West nile vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and West nile vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3657840